Consensus on timing of intervention for common congenital heart disease

1

  • 1Dr. Anita Saxena, Department of Cardiology, All India Institute of Medical Sciences, New Delhi 110 029, India. anitasaxena@hotmail.com.

Indian Pediatrics
|March 4, 2008
PubMed

Insights

Guidelines for pediatric congenital heart disease intervention in India are presented, addressing optimal timing for various conditions. These recommendations aim to improve management for children facing late presentation and other health challenges.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Surgery
  • Public Health

Background:

  • Congenital heart diseases (CHDs) in India often present late, compounded by undernutrition and comorbidities.
  • Existing guidelines may not adequately address the specific needs of Indian children with CHDs.
  • Development of tailored guidelines is crucial for optimizing intervention timing.

Purpose of the Study:

  • To establish evidence-based guidelines for the optimal timing of interventions in pediatric congenital heart diseases.
  • To define criteria for assessing operability in children with left-to-right shunt lesions.
  • To provide recommendations for infective endocarditis prophylaxis in this population.

Main Methods:

  • Guidelines were developed through expert deliberations at a National Consensus Meeting.
  • The meeting was supported by the Cardiological Society of India.
  • The process involved synthesizing evidence to inform recommendations.

Main Results:

  • Recommendations cover timing of intervention for common CHDs, including left-to-right shunts, obstructive lesions, and cyanotic defects.
  • Specific guidance is provided for assessing operability in left-to-right shunt lesions.
  • Evidence-based recommendations for infective endocarditis prophylaxis are included.

Conclusions:

  • The guidelines offer a framework for managing congenital heart diseases in Indian children.
  • They address critical aspects such as intervention timing, operability assessment, and prophylaxis.
  • Implementation of these guidelines aims to improve outcomes for pediatric CHD patients.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...